M. Saunders

发表

Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial. CHART Steering committee.

A Harvey, M. Parmar, A. Barrett, 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

A computerized data collection system for a cancer centre.

S. Dische, M. Saunders, A. M. Elespe, 1994, Clinical oncology (Royal College of Radiologists (Great Britain)).

Misonidazole-a drug for trial in radiotherapy and oncology.

S. Dische, M. Saunders, I. Flockhart, 1979, International journal of radiation oncology, biology, physics.

Radiotherapy with concurrent carbogen and nicotinamide in bladder carcinoma.

P. Hoskin, S. Bentzen, A. Rojas, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The potential advantages of (18)FDG PET/CT-based target volume delineation in radiotherapy planning of head and neck cancer.

I. Kayani, S. Moinuddin, M. Saunders, 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

A pilot study of continuous, hyperfractionated, accelerated radiotherapy in rectal adenocarcinoma.

P. Hoskin, R. Glynne-Jones, M. Saunders, 1999, Clinical oncology (Royal College of Radiologists (Great Britain)).

Antivascular effects of neoadjuvant androgen deprivation for prostate cancer: an in vivo human study using susceptibility and relaxivity dynamic MRI.

D. Collins, A. Padhani, J. d’Arcy, 2011, International journal of radiation oncology, biology, physics.

Carbogen and nicotinamide in locally advanced bladder cancer: early results of a phase-III randomized trial.

P. Hoskin, S. Bentzen, A. Rojas, 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Clinical results of hypoxic cell radiosensitisation from hyperbaric oxygen to accelerated radiotherapy, carbogen and nicotinamide.

S. Dische, M. Saunders, 1996, The British journal of cancer. Supplement.

From CHART to CHARTWEL in non-small cell lung cancer: clinical radiobiological modelling of the expected change in outcome.

S. Dische, S. Bentzen, M. Saunders, 2002, Clinical oncology (Royal College of Radiologists (Great Britain)).

Pre-treatment proliferation and the outcome of conventional and accelerated radiotherapy.

G. Wilson, F. Daley, S. Dische, 2006, European journal of cancer.

Continuous, hyperfractionated, accelerated radiotherapy (CHART) in non-small cell carcinoma of the bronchus.

S. Dische, M. Saunders, 1990, International journal of radiation oncology, biology, physics.

Hyperbaric oxygen and radiotherapy: a Medical Research Council trial in carcinoma of the bladder.

S. Dische, M. Saunders, I. Sutherland, 1978, The British journal of radiology.

A phase I/II study of CHARTWEL with concurrent chemotherapy in locally advanced, inoperable carcinoma of the oesophagus.

J. Harney, P. Hoskin, R. Glynne-Jones, 2003, Clinical oncology (Royal College of Radiologists (Great Britain)).

Non-small cell lung cancer and CHART (continuous hyperfractionated accelerated radiotherapy)--where do we stand?

R. Eakin, M. Saunders, 2000, The Ulster medical journal.

bcl-2 expression in head and neck cancer: an enigmatic prognostic marker.

G. Wilson, P. Richman, S. Dische, 2001, International journal of radiation oncology, biology, physics.

Audit of effectiveness of routine follow-up clinics after radiotherapy for cancer: a report of the REACT working group of ESTRO.

C. Haie-meder, M. Marcenaro, V. Vitale, 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Continuous hyperfractionated accelerated radiotherapy (CHART) in localized cancer of the esophagus.

P. Hoskin, S. Dische, M. Saunders, 1997, International journal of radiation oncology, biology, physics.

Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial

M. Parmar, A. Barrett, S. Dische, 1997, The Lancet.

Evaluation of normal FDG uptake in palatine tonsil and its potential value for detecting occult head and neck cancers: A PET CT study

B. Sanghera, W. Wong, D. Gibson, 2007, Nuclear medicine communications.

The immunohistochemical assessment of hypoxia, vascularity and proliferation in bladder carcinoma.

P. Hoskin, G. Wilson, F. Daley, 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

The impact of FDG PET on the management of occult primary head and neck tumours.

W. Wong, M. Saunders, Wai-Lup Wong, 2003, Clinical oncology (Royal College of Radiologists (Great Britain)).

Inspired and expired gas concentrations in man during carbogen breathing.

H. Baddeley, P. Hoskin, M. Saunders, 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

The modification of human tumour blood flow using pentoxifylline, nicotinamide and carbogen.

P. Hoskin, S. Hill, M. Saunders, 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Accelerated radiotherapy, carbogen, and nicotinamide (ARCON) in the treatment of advanced bladder cancer: mature results of a Phase II nonrandomized study.

P. Hoskin, A. Rojas, M. Saunders, 2009, International journal of radiation oncology, biology, physics.

482 Experience of a dose escalation study using CHARTWEL (continuous hyperfractionated accelerated radiotherapy weekendless) in non-small cell lung cancer

P. Hoskin, M. Saunders, M. Curie, 1997 .

Chest radiography or computed tomography in the assessment of lung cancer prior to radiography.

S. Dische, M. Saunders, B. E. Lyn, 1992, Clinical oncology (Royal College of Radiologists (Great Britain)).

Is control of the primary tumour worthwhile in non-oat cell carcinoma of the bronchus?

M. Saunders, 1991, Clinical oncology (Royal College of Radiologists (Great Britain)).

Clinical experience with nitroimidazoles as radiosensitizers.

S. Dische, M. Stratford, A. Minchinton, 1982, International journal of radiation oncology, biology, physics.

Failure-specific prognostic factors after continuous hyperfractionated accelerated radiotherapy (CHART) or conventional radiotherapy in locally advanced non-small-cell lung cancer: A competing risks analysis

S. Dische, S. Bentzen, M. Saunders, 2001, British Journal of Cancer.

Role of PET FDG in the management of head and neck squamous cell cancer.

W. Wong, M. Saunders, 1998, Clinical oncology (Royal College of Radiologists (Great Britain)).

High FDG uptake in a schwannoma: a PET study.

W. Wong, M. Saunders, A. Sibtain, 2000, Journal of computer assisted tomography.

[(64)Cu]diacetyl-bis(N(4)-methyl-thiosemicarbazone) - a radiotracer for tumor hypoxia.

W. Wong, K. Wood, M. Saunders, 2008, Nuclear medicine and biology.

Pretreatment minimal staging for non-small cell lung cancers: a consensus report

U. Pastorino, R. Stahel, A. Turrisi, 1991 .

Where exactly does failure occur after radiation in head and neck cancer?

S. Dische, M. Saunders, K. Pigott, 1995, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Radiotherapy employing three fractions on each of twelve consecutive days.

J. Fowler, S. Dische, J. Denekamp, 1988, Acta oncologica.

Dose-escalation with CHARTWEL (continuous hyperfractionated accelerated radiotherapy week-end less) combined with neo-adjuvant chemotherapy in the treatment of locally advanced non-small cell lung cancer.

A. Rojas, M. Saunders, E. Wilson, 2002, Clinical oncology (Royal College of Radiologists (Great Britain)).

Smoking and mucosal reactions to radiotherapy.

S. Dische, M. Saunders, T. Rugg, 1990, The British journal of radiology.

Human tumor blood flow is enhanced by nicotinamide and carbogen breathing.

P. Hoskin, S. Hill, M. Saunders, 1997, Cancer research.

Compliance to the prescribed dose and overall treatment time in five randomized clinical trials of altered fractionation in radiotherapy for head-and-neck carcinomas.

J. Horiot, J. Bernier, S. Dische, 2003, International journal of radiation oncology, biology, physics.

The concentration of desmethylmisonidazole in human tumours and in cerebrospinal fluid.

S. Dische, M. Stratford, P. Riley, 1981, British Journal of Cancer.

A serial study of the concentration of misonidazole in human tumors correlated with histologic structure.

T. Rich, S. Dische, M. Stratford, 1981, International journal of radiation oncology, biology, physics.

Neurotoxicity with desmethylmisonidazole.

S. Dische, M. Stratford, M. Saunders, 1981, British Journal of Radiology.

Clinical testing of the radiosensitizer Ro 07-0582: experience with multiple doses.

G. Adams, S. Dische, M. Saunders, 1977, British Journal of Cancer.

The radiosensitizer Ro 03-8799 and the concentrations which may be achieved in human tumours: a preliminary study.

S. Dische, M. Saunders, J. G. Allen, 1982, British Journal of Cancer.

The clinical testing of Ro 03-8799--pharmacokinetics, toxicology, tissue and tumor concentrations.

S. Dische, M. Stratford, A. Minchinton, 1984, International journal of radiation oncology, biology, physics.

18F-fluorodeoxyglucose positron emission tomography/computed tomography in the assessment of occult primary head and neck cancers--an audit and review of published studies.

W. Wong, L. Sonoda, D. Wellsted, 2012, Clinical oncology (Royal College of Radiologists (Great Britain)).

Hemoglobin, radiation, morbidity and survival.

S. Dische, M. Saunders, M. F. Warburton, 1986, International journal of radiation oncology, biology, physics.

The long-term outcome after radical radiotherapy for advanced head and neck cancer.

S. Dische, M. Saunders, K. Pigott, 1993, Clinical oncology (Royal College of Radiologists (Great Britain)).

An audit of head and neck cancer treatment in a Regional Centre for Radiotherapy and Oncology.

S. Dische, A. Hong, M. Saunders, 1990, Clinical oncology (Royal College of Radiologists (Great Britain)).

The long-term outcome after radical radiotherapy for advanced localized non-small cell carcinoma of the lung.

M. Saunders, K. Pigott, 1993, Clinical oncology (Royal College of Radiologists (Great Britain)).

UPDATED DATA FOR CHART IN NSCLC: FURTHER ANALYSES

M. Parmar, S. Dische, S. Bentzen, 2000 .

Carbogen and nicotinamide in the treatment of bladder cancer with radical radiotherapy.

P. Hoskin, M. Stratford, A. Rojas, 1997, British Journal of Cancer.

A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer

M. Parmar, S. Dische, M. Saunders, 1998 .

The dental problems of patients with head and neck cancer treated with CHART.

S. Dische, D. Roos, M. Saunders, 1996, European journal of cancer. Part B, Oral oncology.

The problem of cigarette smoking in radiotherapy for cancer in the head and neck.

S. Dische, M. Saunders, C. Des Rochers, 1992, Clinical oncology (Royal College of Radiologists (Great Britain)).

Continuous, hyperfractionated, accelerated radiotherapy (CHART) in non-small cell lung cancer

S. Dische, M. Saunders, B. E. Lyn, 1993 .

Management of cancer of the head and neck--a cocktail with your PORT?

A. Rojas, M. Saunders, 2004, The New England journal of medicine.

Radiotherapy with three fractions per day for twelve consecutive days for tumors of the thorax, head and neck.

J. Fowler, S. Dische, J. Denekamp, 1988, Frontiers of radiation therapy and oncology.

From the laboratory to the clinic: the "prevalence effect".

H. Rockette, D. Gur, T. Warfel, 2003, Academic radiology.

The neurotoxicity of misonidazole: pooling of data from five centres.

T. Phillips, N. Bleehen, T. Wasserman, 1978, British Journal of Radiology.

Who gets radiotherapy?

S. Dische, M. Saunders, E. Maher, 1990, Health trends.

Pre-treatment haemoglobin concentration in accelerated and conventional radiotherapy for non-small cell lung carcinoma.

P. Hoskin, S. Bentzen, M. Saunders, 2004, Clinical oncology (Royal College of Radiologists (Great Britain)).

Consensus: the follow-up of the treated patient.

P. Postmus, V. Ninane, R. Pirker, 2003, Lung cancer.

Complexity and simplicity in the measurement and recording of the adverse effects of cancer treatment.

S. Dische, M. Saunders, 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Late effects of dose fractionation on the mechanical properties of breast skin following post-lumpectomy radiotherapy.

L. Pierce, S. Dische, A. Lichter, 1999, International journal of radiation oncology, biology, physics.

Positron emission tomography in oncology: a review.

P. Hoskin, K. Wood, P J Hoskin, 2007, Clinical oncology (Royal College of Radiologists (Great Britain)).

Hyperfractionated or accelerated radiotherapy in lung cancer: an individual patient data meta-analysis.

R. Arriagada, J. Pignon, S. Mandrekar, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Continuous hyperfractionated accelerated radiotherapy in locally advanced carcinoma of the head and neck region.

S. Dische, A. Hong, M. Saunders, 1989, International journal of radiation oncology, biology, physics.

A pilot study of postoperative CHART and CHARTWEL in head and neck cancer.

S. Dische, M. Saunders, N. Shah, 2000, Clinical oncology (Royal College of Radiologists (Great Britain)).

Continuous hyperfractionated accelerated radiotherapy in the treatment of carcinoma of the columella and vestibule of the nose.

S. Dische, M. Saunders, C. Lochrin, 1995, European journal of cancer. Part B, Oral oncology.

A drug for improved radiosensitization in radiotherapy.

J. Fowler, S. Dische, M. Stratford, 1980, British Journal of Cancer.

Clinical experience with misonidazole.

S. Dische, M. Saunders, 1978, The British journal of cancer. Supplement.

Quality assurance in the CHART clinical trial.

S. Dische, E. Aird, M. Saunders, 1995, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Measurement of cell kinetics in human tumours in vivo using bromodeoxyuridine incorporation and flow cytometry.

M. I. Saunders, G. Wilson, G. Wilson, 1988, British Journal of Cancer.

Epidermal growth factor receptor expression in pretreatment biopsies from head and neck squamous cell carcinoma as a predictive factor for a benefit from accelerated radiation therapy in a randomized controlled trial.

K. Trott, G. Wilson, F. Daley, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

BOLD MRI of human tumor oxygenation during carbogen breathing

J R Griffiths, A R Padhani, H Baddeley, 2001, Journal of magnetic resonance imaging : JMRI.

Predictive testing of radiosensitivity in non-small cell carcinoma of the lung.

M. Saunders, 1994, Lung cancer.

Administration of nicotinamide during chart: pharmacokinetics, dose escalation, and clinical toxicity.

P. Hoskin, M. Stratford, A. Rojas, 1995, International journal of radiation oncology, biology, physics.

Tumor antivascular effects of radiotherapy combined with combretastatin a4 phosphate in human non-small-cell lung cancer.

Vicky Goh, V. Goh, A. Padhani, 2007, International journal of radiation oncology, biology, physics.

Effect of nitric-oxide synthesis on tumour blood volume and vascular activity: a phase I study.

Vicky Goh, V. Goh, Q. Ng, 2007, The Lancet. Oncology.

Acute tumor vascular effects following fractionated radiotherapy in human lung cancer: In vivo whole tumor assessment using volumetric perfusion computed tomography.

Vicky Goh, V. Goh, A. Padhani, 2007, International journal of radiation oncology, biology, physics.

A feasibility study of continuous hyperfractionated accelerated radiotherapy (CHART) and brachytherapy in patients with early oral or oropharyngeal carcinomas.

P. Hoskin, S. Dische, M. Saunders, 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Mature results of a randomized trial of accelerated hyperfractionated versus conventional radiotherapy in head-and-neck cancer.

M. Parmar, S. Dische, A. Rojas, 2010, International journal of radiation oncology, biology, physics.

Primary tumor control after radiotherapy for carcinoma of the bronchus.

S. Dische, M. Saunders, P. Anderson, 1984, International journal of radiation oncology, biology, physics.

The relationship between tumor response and survival following radiotherapy for carcinoma of the bronchus.

S. Dische, M. Saunders, P. Anderson, 1984, International journal of radiation oncology, biology, physics.

Quantitative helical dynamic contrast enhanced computed tomography assessment of the spatial variation in whole tumour blood volume with radiotherapy in lung cancer.

V. Goh, Q. Ng, P. Hoskin, 2010, Lung cancer.

An immunohistochemical assessment of hypoxia in prostate carcinoma using pimonidazole: implications for radioresistance.

P. Hoskin, F. Daley, S. Bentzen, 2006, International journal of radiation oncology, biology, physics.

Carcinoma of the cervix and the use of hyperbaric oxygen with radiotherapy: a report of a randomised controlled trial.

S M Bentzen, S. Dische, S. Bentzen, 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Phase Ib trial of radiotherapy in combination with combretastatin-A4-phosphate in patients with non-small-cell lung cancer, prostate adenocarcinoma, and squamous cell carcinoma of the head and neck.

V. Goh, A. Padhani, H. Mandeville, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Cell proliferation and differentiation in squamous cancer.

G. Wilson, S. Dische, N. J. McNally, 1989, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

A controlled clinical trial of misonidazole in the radiotherapy of patients with carcinoma of the bronchus.

S. Dische, W. Martin, M. Saunders, 1982, International journal of radiation oncology, biology, physics.

Desmethylmisonidazole (Ro 05-9963): clinical pharmacokinetics after multiple oral administration.

S. Dische, M. Stratford, A. Minchinton, 1982, International journal of radiation oncology, biology, physics.

Effect of carbogen breathing on tumour microregional blood flow in humans.

P. Hoskin, S. Hill, P J Hoskin, 1996, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer.

M. Parmar, A. Barrett, S. Dische, 1997, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Repair halftimes estimated from observations of treatment-related morbidity after CHART or conventional radiotherapy in head and neck cancer.

S M Bentzen, S. Dische, S. Bentzen, 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Adaptive 18fluoro-2-deoxyglucose positron emission tomography/computed tomography-based target volume delineation in radiotherapy planning of head and neck cancer.

B. Sanghera, I. Kayani, W. Wong, 2011, Clinical oncology (Royal College of Radiologists (Great Britain)).

Cost Effectiveness of Modified Fractionation Radiotherapy versus Conventional Radiotherapy for Unresected Non–Small-Cell Lung Cancer Patients

H. Choy, R. Arriagada, J. Pignon, 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Radiotherapy for inoperable lung cancer.

D. Girling, P. Hoskin, F. Macbeth, 2001, Clinical oncology (Royal College of Radiologists (Great Britain)).

Sweat gland function as a measure of radiation change.

B. Vojnovic, S. Dische, M. Saunders, 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Gas exchange parameters in radiotherapy patients during breathing of 2%, 3.5% and 5% carbogen gas mixtures.

H Baddeley, H. Baddeley, P. Hoskin, 2000, The British journal of radiology.

Improvement in human tumour oxygenation with carbogen of varying carbon dioxide concentrations.

P. Hoskin, S. Hill, P J Hoskin, 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Short communication: the addition of carbogen and nicotinamide to a palliative fractionation schedule for locally advanced breast cancer.

S. Dische, M. Saunders, K. Pigott, 1995, The British journal of radiology.

Hyperbaric oxygen and radiotherapy: a Medical Research Council trial in carcinoma of the cervix.

G Wiernik, K E Halnan, S. Dische, 1978, The British journal of radiology.

The response of human tumors to carbogen breathing, monitored by Gradient-Recalled Echo Magnetic Resonance Imaging.

J R Griffiths, F A Howe, H Baddeley, 1997, International journal of radiation oncology, biology, physics.

Randomised multicentre trials of CHART vs conventional radiotherapy in head and neck and non-small-cell lung cancer: an interim report. CHART Steering Committee.

M. I. Saunders, M. Parmar, A. Barrett, 1996, British Journal of Cancer.

Programming of radiotherapy in the treatment of non-small-cell lung cancer--a way to advance care.

M. Saunders, 2001, The Lancet. Oncology.

Fractionation and dose in thoracic radiotherapy.

M. Saunders, 1994, Lung cancer.

The rationale for continuous, hyperfractionated, accelerated radiotherapy (CHART).

S. Dische, M. Saunders, 1990, International journal of radiation oncology, biology, physics.

Precision in reporting the dose given in a course of radiotherapy

S. Dische, E. Aird, M. Saunders, 1994 .

The value of pretreatment cell kinetic parameters as predictors for radiotherapy outcome in head and neck cancer: a multicenter analysis.

J C Horiot, A. Hart, H. Bartelink, 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Tumour proliferation assessed by combined histological and flow cytometric analysis: implications for therapy in squamous cell carcinoma in the head and neck.

G. Wilson, G. Wilson, S. Dische, 1992, British Journal of Cancer.

Molecular biomarkers and site of first recurrence after radiotherapy for head and neck cancer.

G. Wilson, F. Daley, S. Dische, 2004, European journal of cancer.

Toxicity and outcome of a phase II trial of taxane‐based neoadjuvant chemotherapy and 3‐dimensional, conformal, accelerated radiotherapy in locally advanced nonsmall cell lung cancer

A. Rojas, J. Dickson, M. Saunders, 2006, Cancer.

Continuous, hyperfractionated, accelerated radiotherapy (CHART): an interim report upon late morbidity.

S. Dische, M. Saunders, Stanley Dische, 1989, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Hypoxia in prostate cancer: correlation of BOLD-MRI with pimonidazole immunohistochemistry-initial observations.

David J Collins, Søren M Bentzen, James A d'Arcy, 2007, International journal of radiation oncology, biology, physics.

Quantitative assessment of lung cancer perfusion using MDCT: does measurement reproducibility improve with greater tumor volume coverage?

H. Fichte, V. Goh, E. Klotz, 2006, AJR. American journal of roentgenology.

CHART revisited: a conservative approach for advanced head and neck cancer.

S. Dische, A. Rojas, M. Saunders, 2008, Clinical oncology (Royal College of Radiologists (Great Britain)).

S. Dische, S. Bentzen, S. Bond, 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Tumour regression and prognosis: a clinical study.

S. Dische, M. Saunders, 1980, The British journal of cancer. Supplement.

Low dose hyper-radiosensitivity in metastatic tumors.

Susan C Short, J. Harney, S. Short, 2004, International journal of radiation oncology, biology, physics.

The evaluation of low dose hyper-radiosensitivity in normal human skin.

J. Harney, G. Wilson, S. Short, 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Endogenous markers of two separate hypoxia response pathways (hypoxia inducible factor 2 alpha and carbonic anhydrase 9) are associated with radiotherapy failure in head and neck cancer patients recruited in the CHART randomized trial.

A. Harris, G. Wilson, F. Daley, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Experience with CHART.

S. Dische, M. Saunders, E. Maher, 1991, International journal of radiation oncology, biology, physics.

Time course from first symptom to treatment in patients with non-small cell lung cancer referred for radiotherapy: a report by the CHART Steering Committee.

M. Parmar, S. Dische, M. Saunders, 1996, Thorax.

A comparison of the tumour concentrations obtainable with misonidazole and Ro 03-8799.

S. Dische, M. Stratford, P. Wardman, 1986, The British journal of radiology.

Radiation myelitis and survival in the radiotherapy of lung cancer.

S. Dische, M. Saunders, M. F. Warburton, 1988, International journal of radiation oncology, biology, physics.

Concentrations achieved in human tumors after administration of misonidazole, SR-2508 and Ro 03-8799.

S. Dische, M. Stratford, A. Minchinton, 1986, International journal of radiation oncology, biology, physics.

Molecular Marker Profiles Predict Locoregional Control of Head and Neck Squamous Cell Carcinoma in a Randomized Trial of Continuous Hyperfractionated Accelerated Radiotherapy

Stanley Dische, George D Wilson, Søren M Bentzen, 2004, Clinical Cancer Research.

Tumor cell kinetics, local tumor control, and accelerated radiotherapy: a preliminary report.

G. Wilson, S. Dische, N. J. McNally, 1992, International journal of radiation oncology, biology, physics.

Dynamic contrast enhanced magnetic resonance scanning as a predictor of response to accelerated radiotherapy for advanced head and neck cancer.

H Baddeley, H. Baddeley, P. Hoskin, 1999, The British journal of radiology.

The role of radiotherapy in carcinoma of the thoracic oesophagus: an audit of the Mount Vernon experience 1980-1989.

S. Dische, M. Saunders, E. Maher, 1992, Clinical oncology (Royal College of Radiologists (Great Britain)).

Lung cancer perfusion at multi-detector row CT: reproducibility of whole tumor quantitative measurements.

Ernst Klotz, Vicky Goh, Heinz Fichte, 2006, Radiology.

Volumetric perfusion CT assessment of concurrent combretastatin-A4-phosphate (CA4P) and radiotherapy (RT) in non-small cell lung cancer

V. Goh, H. Mandeville, Q. Ng, 2008 .

Continuous, hyperfractionated, accelerated radiotherapy (CHART).

M. I. Saunders, S. Dische, S. Dische, 1989, British Journal of Cancer.

Overall treatment time and the conventional arm of the CHART trial in the radiotherapy of head and neck cancer.

M. Parmar, S. Dische, G. Griffiths, 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Chest radiography or computed tomography to assess the response of lung cancer to radiotherapy.

S. Dische, M. Saunders, B. E. Lyn, 1992, Clinics in oncology.

Microregional blood flow in murine and human tumours assessed using laser Doppler microprobes.

P. Hoskin, M. Leahy, D. Chaplin, 1996, The British journal of cancer. Supplement.

Direct comparison of bromodeoxyuridine and Ki‐67 labelling indices in human tumours

G. Wilson, P. Richman, S. Dische, 1996, Cell proliferation.

Bcl-2 expression correlates with favourable outcome in head and neck cancer treated by accelerated radiotherapy.

G. Wilson, P. Richman, S. Dische, 1996, Anticancer Research.

Studies with bromodeoxyuridine in head and neck cancer and accelerated radiotherapy.

G. Wilson, S. Dische, M. Saunders, 1995, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Reproducibility and correlation between quantitative and semiquantitative dynamic and intrinsic susceptibility‐weighted MRI parameters in the benign and malignant human prostate

David J Collins, James A d'Arcy, D. Collins, 2010, Journal of magnetic resonance imaging : JMRI.

Skin rashes associated with the administration of the 2-nitroimidazole, misonidazole.

S. Dische, M. Saunders, H. Kogelnik, 1980, Cancer treatment reports.

Head and neck cancer: altered fractionation schedules.

M. Saunders, 1999, The oncologist.

Fractionation in radiotherapy: a view from the clinic.

S. Dische, M. Saunders, 1997, The British journal of radiology.

Fractionation as a Biological Dose Modifier

M. Saunders, 1999 .

Microregional fluctuations in perfusion within human tumours detected using laser Doppler flowmetry.

D. Chaplin, S. Hill, M. Saunders, 1996, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Experience with dose escalation using CHARTWEL (continuous hyperfractionated accelerated radiotherapy weekend less) in non-small-cell lung cancer.

P. Hoskin, A. Rojas, M. Saunders, 1998, British Journal of Cancer.

Carbogen breathing increases prostate cancer oxygenation: a translational MRI study in murine xenografts and humans

D J Collins, A R Padhani, R J Maxwell, 2009, British Journal of Cancer.

Acute and late morbidity in the treatment of advanced bladder carcinoma with accelerated radiotherapy, carbogen, and nicotinamide

P. Hoskin, A. Rojas, M. Saunders, 2005, Cancer.

The morbidity of salvage surgery following conventional radiotherapy and continuous, hyperfractionated accelerated radiotherapy (CHART).

R. Sanders, S. Dische, E. Lartigau, 1991, International journal of radiation oncology, biology, physics.

Precision in reporting the dose given in a course of radiotherapy.

S. Dische, E. Aird, M. Saunders, 1993, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Combined radiation and chemotherapy for unresectable non-small cell lung carcinoma.

E. Shaw, N. Bleehen, J. Cox, 1994, Lung cancer.

Accelerated radiotherapy, carbogen and nicotinamide (ARCON) in locally advanced head and neck cancer: a feasibility study.

P. Hoskin, S. Dische, J. Denekamp, 1997, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

99 Randomised multicentre trial of chart versus conventional radiotherapy in non-small lung cancer — Interim results and implications

S. Dische, M. Saunders, 1996 .

The optimum regime for the administration of misonidazole and the establishment of multi-centre clinical trials.

S. Dische, M. Saunders, I. Flockhart, 1978, The British journal of cancer. Supplement.

Lung function and radiation response.

S. Dische, A. Hong, P. Lockwood, 1991, The British journal of radiology.

Nicotinamide pharmacokinetics in normal volunteers and patients undergoing palliative radiotherapy.

P. Hoskin, M. Stratford, A. Rojas, 1996, Acta oncologica.

Cost Effectiveness of Modified Fractionation Radiotherapy versus Conventional Radiotherapy for Unresected Non–Small-Cell Lung Cancer Patients

H. Choy, R. Arriagada, J. Pignon, 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

The pharmacokinetics of a new radiosensitiser, Ro 03-8799 in humans

S. Dische, M. Saunders, S. Malcolm, 2004, European Journal of Clinical Pharmacology.

BOLD MRI of human tumor oxygenation during carbogen breathing

J. Griffiths, H. Baddeley, A. Padhani, 2001, Journal of magnetic resonance imaging : JMRI.

Potential novel application of dual time point SUV measurements as a predictor of survival in head and neck cancer

Martin A Lodge, Bal Sanghera, Wai Lup Wong, 2005, Nuclear medicine communications.

Hyperfractionated or accelerated radiotherapy in lung cancer: an individual patient data meta-analysis.

R. Arriagada, J. Pignon, S. Mandrekar, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Accelerated radiotherapy vs. chemoradiation in non-small cell lung cancer: quantifying the hazards.

M. Parmar, S. Dische, S. Bentzen, 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Radiotherapy employing three fractions in each day over a continuous period of 12 days.

S. Dische, M. Saunders, M I Saunders, 1986, The British journal of radiology.

The value of pretreatment cell kinetic parameters as predictors for radiotherapy outcome in head and neck cancer: a multicenter analysis.

A. Hart, H. Bartelink, J. Horiot, 1999, Radiotherapy and Oncology.